JOE TOSCANO: Open Payments
NPI 1477868842 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 39 payments from 10 companies in 2025. Trend: 2023 $125 · 2024 $634 · 2025 $815
Food & beverage: $803Education: $12
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $161 |
| GENZYME CORPORATION | 13 | $156 |
| Regeneron Healthcare Solutions, Inc. | 8 | $145 |
| ABBVIE INC. | 4 | $108 |
| LEO Pharma Inc. | 4 | $79 |
| Paratek Pharmaceuticals, Inc. | 3 | $59 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Almirall LLC | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, ADBRY, NUZYRA, BLU-U, COSENTYX, Klisyri.
Industry payments across TX — which companies pay providers there.
